Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.

Literature DB >> 12357373

Imatinib mesylate-induced hepato-toxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis.

K Ohyashiki, Y Kuriyama, A Nakajima, T Tauchi, Y Ito, H Miyazawa, Y Kimura, H Serizawa, Y Ebihara.

Abstract

Entities: Chemical Disease

Mesh：

Substances：

Year: 2002 PMID： 12357373 DOI： 10.1038/sj.leu.2402702

Source DB: PubMed Journal: Leukemia ISSN： 0887-6924 Impact factor: 11.528

Keyword Cloud
Cited

× No keyword cloud information.

14 in total

1. Imatinib mesylate (gleevec) hepatotoxicity.

Authors: Ayse L Mindikoglu; Arie Regev; Pablo A Bejarano; Enrique J Martinez; Lennox J Jeffers; Eugene R Schiff
Journal: Dig Dis Sci Date: 2007-01-12 Impact factor: 3.199

2. Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management.

Authors: Katsuya Ikuta; Yoshihiro Torimoto; Junko Jimbo; Junki Inamura; Motohiro Shindo; Kazuya Sato; Yoshihiko Tokusashi; Naoyuki Miyokawa; Yutaka Kohgo
Journal: Int J Hematol Date: 2005-11 Impact factor: 2.490

Review 3. Kinase inhibitors and monoclonal antibodies in oncology: clinical implications.

Authors: Helen Gharwan; Hunter Groninger
Journal: Nat Rev Clin Oncol Date: 2015-12-31 Impact factor: 66.675

Review 4. Hepatotoxicity of tyrosine kinase inhibitors: clinical and regulatory perspectives.

Authors: Rashmi R Shah; Joel Morganroth; Devron R Shah
Journal: Drug Saf Date: 2013-07 Impact factor: 5.606

5. Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors.

Authors: Onder Tonyali; Ugur Coskun; Ramazan Yildiz; Tarkan Karakan; Umut Demirci; Nalan Akyurek; Mustafa Benekli; Suleyman Buyukberber
Journal: Med Oncol Date: 2009-08-07 Impact factor: 3.064

Review 6. Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review.

Authors: Veerandra Kumar; Priyanka Singh; Sonu Kumar Gupta; Villayat Ali; Malkhey Verma
Journal: Mol Cell Biochem Date: 2022-02-07 Impact factor: 3.396

Review 7. Successful imatinib treatment of cardiac involvement of FIP1L1-PDGFRA-positive chronic eosinophilic leukemia followed by severe hepatotoxicity.

Authors: Ayako Arai; Weihua Yan; Shihoko Wakabayashi; Shin Hayashi; Johji Inazawa; Osamu Miura
Journal: Int J Hematol Date: 2007-10 Impact factor: 2.490